placebo matching canakinumab

DRUG2 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

Arthritis, GoutyGout

Phase 2

Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

CompletedNCT00663169

NovartisArthritis, Gouty

Start: 2008-04-30End: 2009-10-31Updated: 2013-01-07

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

CompletedNCT00819585

Novartis PharmaceuticalsGout

Start: 2008-12-31End: 2010-08-31Updated: 2018-07-17